2001-007: A Safety Trial Using Recombinant Urokinase (ABT-120, Urokinase Alpha) in the Treatment of Occluded Venous

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/029/30/03

Funding

  • Abbott Laboratories: $7,380.00